The short answer
As a broad guide, Australian physiotherapy and allied health clinics change hands at somewhere between two and four times normalised EBITDA. Owner-operated single-site clinics where the principal carries the caseload sit toward the bottom of that band — and sometimes below it. Multi-practitioner clinics with genuine systems, spread referral bases and low owner dependence support multiples of three and a half to five times, particularly where allied health aggregators and private-equity-backed roll-ups are competing for the asset. A roll-up paying at the top of the range is pricing a platform strategy and the principal’s committed future labour, not the clinic as it stands — a distinction this article returns to. The honest observation about these benchmarks is that the spread within them matters more than the benchmarks themselves: two clinics with identical revenue can defensibly land at values several hundred thousand dollars — or several multiples — apart, and the factor doing most of the work is a single question. When the principal hands back the keys, does the caseload stay or leave?
Why do physio clinics with the same revenue sell for different prices?
The answer is goodwill transfer: two physiotherapy clinics with identical revenue can be worth very different amounts depending on how much of the patient relationship belongs to the clinic rather than the treating practitioner. Goodwill is the bulk of any clinic’s value, and in allied health the valuation question is never how much goodwill exists — it is how much of it transfers. Personal goodwill attaches to the practitioner: the patients who rebook with a specific physio, the GP who refers to a name rather than a clinic, the surgeon whose post-operative protocol names an individual. It leaves at settlement. Transferable goodwill attaches to the clinic: the location, the brand, the online booking system, the recall program, the class timetable, the employed team and the patient database. Market value — the willing-but-not-anxious standard from Spencer v Commonwealth (1907), carried through IVS 104 — is a price for what remains after the vendor departs, so the analysis has to separate the two rather than assert an answer. The evidence that settles it is specific and usually already sitting in the practice-management system: rebooking rates by practitioner, the share of new patients who book the clinic rather than request a clinician, referrer-level analysis of where the caseload originates, and — most tellingly — what happened to billings the last time a senior physio left. A clinic that has watched a departing practitioner take three hundred consultations a year down the road already knows what its personal goodwill is worth to a buyer.
Is a solo physiotherapist’s clinic worth less than a multi-practitioner clinic?
Yes, in most cases: a solo-practitioner physiotherapy clinic is typically worth less relative to its revenue than a multi-practitioner clinic, because more of the goodwill is personal to the treating physio and does not transfer at sale. Dependence is a spectrum, and the valuation response is a measured adjustment, not a slogan. At one end sits the solo practitioner clinic: the principal is the product, and what a buyer acquires is fit-out, equipment, a lease, a phone number and a caseload that may or may not tolerate a stranger. Transferable goodwill in a genuinely solo clinic can be close to nil, which is why such clinics often change hands near net asset value plus a modest goodwill payment tied to a handover period — the buyer is substantially buying a job. At the other end sits the multi-practitioner clinic where the principal treats a day or two a week, the team carries the caseload, and the systems carry the team. Between the two, the discount is quantified from provider-level billing reports — the principal’s percentage of gross fees is a number, not an impression — and tested against the durability of everything else. High dependence shows up as a lower multiple, a specific key-person risk discount, or both, with the reasoning documented rather than asserted. The mitigants a valuation file gives weight to are equally concrete:
- ·The principal’s share of billings, measured from provider-level reports over at least two years
- ·Associate tenure, and whether associates hold their own recall bases and referral relationships
- ·A practice manager and documented clinical, recall and rostering systems that run without the owner
- ·New-patient flow spread across many referrers and direct bookings, rather than two or three personal relationships
- ·Restraint and transition arrangements that keep the principal clinically present through a handover — and would actually hold
Does NDIS or Medicare revenue reduce a physiotherapy clinic’s value?
Revenue priced by a government scheme is generally treated as lower-quality earnings than private fee-for-service revenue, because the clinic does not control the price and carries scheme-specific compliance and payment risk — so a physiotherapy clinic with a heavier NDIS, Medicare or compensable-scheme mix typically supports a lower multiple on that portion of earnings. Physiotherapy revenue is rarely one market, and a valuation that treats a dollar of revenue as a dollar of revenue regardless of source has skipped a step. Private fee-for-service is the strongest book: the clinic sets its own fees, subject to local competition and health-fund rebate settings. NDIS revenue is price-administered: at the time of writing the national price limit for physiotherapy is $183.99 per hour — reduced in the 2025–26 pricing arrangements and held unchanged in the 2026–27 NDIS Pricing Schedule that applies from 1 July 2026. An NDIS-heavy book means the clinic’s pricing decisions are made by the agency’s annual review, not at the front desk, and it carries plan-management payment risk and a compliance load a buyer will price. DVA treatment of entitled veterans is billed at departmental scheduled fees — reliable payment, capped price. Medicare chronic-condition referrals under item 10960 allow up to five allied health services per patient per calendar year under a GP chronic condition management plan (the single plan that replaced the former GP management plan and team care arrangements from 1 July 2025); the rebate sits well below most clinics’ private fee, so the economics of that book depend entirely on the clinic’s gap-fee policy. Compensable schemes — workers compensation and CTP — pay at gazetted rates with insurer approval cycles, report-writing burden and, frequently, referral relationships with case managers that are personal to the principal. The valuation work is twofold: restate maintainable earnings for announced price settings rather than historical ones, and run a concentration analysis by payor exactly as one would for a customer book. A clinic earning sixty per cent of its fees from administered prices is a different risk asset from a private-fee clinic with the same EBITDA, and the multiple should say so.
Does spare treatment-room capacity add value to a physio clinic?
Spare capacity adds value only when it is evidenced demand a buyer can step into, not simply an empty room — treatment rooms are the clinic’s productive capacity, and utilisation is the first operational question a sophisticated buyer asks. A four-room clinic running three rooms five days a week is a different asset from the same clinic running four rooms across extended hours — even at identical current fees — because one has demonstrated headroom and the other is at its ceiling. But capacity is only worth something when the evidence supports unmet demand: an empty room is upside if the appointment book, waitlist and new-patient flow show patients the clinic could not fit in, and merely a cost if they do not. Vendors are routinely tempted to price the potential; a valuer prices maintainable earnings and lets documented capacity inform where within the supportable range the conclusion sits. The analysis pairs revenue per practitioner-hour against cost per practitioner-hour — physiotherapy is a labour business, and the margin lives in that spread. The evidence that does the work:
- ·Treating hours by practitioner and by room against the hours the fit-out could support
- ·Appointment-book utilisation and waitlist data over at least twelve months
- ·Rebooking rates and average episode-of-care length by practitioner
- ·New-patient flow by source — GP referral, compensable, NDIS, direct and online booking
- ·Group, class and gym-floor revenue per available session, where the clinic runs them
A worked example: same revenue, very different value
Two physiotherapy clinics with identical revenue and identical reported EBITDA can carry supportable values almost three times apart once practitioner dependence and payor mix are priced separately. Consider two clinics, each with gross fees of $1.5m and reported EBITDA of $400k. Clinic A is principal-led: she personally generates $450k of the fees, holds the relationships with the two GP practices and the orthopaedic surgeon who supply most new patients, and has never drawn a market wage — the profit is her income. Two of her four physios have been there under a year. Normalisation prices her replacement: a senior clinician package covering her treating load and clinical-director role costs roughly $160k, taking normalised EBITDA to about $240k. Dependence and referral concentration put the supportable multiple at 2.0 to 2.5 times — an enterprise value bracket of roughly $480k to $600k. Clinic B has the same top line and the same reported earnings, but the principal treats one day a week on a market wage already booked through the accounts, seven physios average more than four years’ tenure, a practice manager runs the roster and recall system, and new patients arrive from dozens of referrers and direct bookings across a balanced payor mix. Normalisation is minor; maintainable EBITDA lands near $380k. A multiple of 3.5 to 4.25 times is supportable — roughly $1.33m to $1.6m. Same revenue, same reported profit: the supportable values sit almost three times apart. Nothing in the gap is mysterious, and every figure in this example is illustrative rather than a benchmark — but the gap itself is real, it is the ordinary consequence of dependence and payor mix, and it is why a clinic that spends two or three years reducing its principal-dependence before sale is often buying itself the best return available in the industry.
Do I need a formal valuation to sell a physio clinic or claim CGT concessions?
A formal valuation is not a legal requirement to sell a physiotherapy clinic, but it becomes necessary wherever a tax position, a related-party transaction or a disputed price needs evidence behind it. For many principals the clinic sale is the retirement event, and the small business CGT concessions in Division 152 of the ITAA 1997 determine how much of the proceeds are kept. The sale price itself is usually not the valuation issue — an arm’s-length price stands as the capital proceeds. The valuation issue is eligibility: the maximum net asset value test requires the net value of the CGT assets of the taxpayer, connected entities and affiliates to be no more than $6m just before the CGT event, and for clinic owners that calculation typically sweeps in the service entity, related trusts and any premises held outside the operating company. The active asset test — with “active asset” defined in s 152-40 — raises its own questions where a service arrangement sits between the entities, including which entity actually owns the goodwill. Where the transfer is not at arm’s length — a partner buy-in at friendly terms, a transfer into a family trust — market value substitution under s 116-30 can apply, and the value in the file is the value the position rests on if reviewed. For those matters the file needs a signed valuation prepared under APES 225, with methodology stated and evidence retained, prepared with the ATO’s market valuation guidance in mind so the position is defensible if reviewed. Prismi’s Essential report (from $1,495 + GST) suits straightforward single-methodology matters; Comprehensive (from $3,995 + GST) is typically the right tier for clinic sales and buy-ins carrying normalisation and dependence questions; the Defensible Valuation File (from $8,995 + GST) is the level small business CGT concession claims and review-likely matters warrant.
The supportable answer
A physiotherapy clinic is worth a supportable range, and the honest answer to “how much is my clinic worth” starts with the uncomfortable questions: what does replacing the principal’s treating hours actually cost, how much of the caseload survives her departure, and how much of the revenue is priced by a regulator rather than the front desk. Our reports conclude at the most supportable position within that range, with the dependence analysis, the payor-mix treatment and every normalisation adjustment documented — senior-reviewer signed under an independence statement, working file retained ten years, fees fixed at engagement and never contingent on the outcome. Where a vendor wants a number that flatters the negotiation rather than the position the evidence defends, we will say so and decline the engagement on those terms. One boundary worth stating plainly: Prismi prepares independent valuations only. We are not registered tax agents and do not provide tax, legal or financial advice — concession eligibility, transaction structure and the treatment of any earn-out belong with the clinic’s accountant and lawyer, working from the valuation evidence.